La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge nearly 11% on the day. This led to far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock has risen 20.5% since May 5, 2015.
In the last 30 days, the company witnessed 1 downward estimate revision and the Zacks Consensus Estimate of a loss widened over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
La Jolla Pharmaceutical currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
An attractive player in the same industry includes Indivior PLC (INVVY) sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment